Common Genetic Risk Seen for Primary Ovarian Insufficiency, Cancer
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 31, 2024 -- There seems to be a common genetic risk for primary ovarian insufficiency (POI) and reproductive cancer risk, according to a study published online July 12 in the Journal of Clinical Endocrinology & Metabolism.
Kristina Allen-Brady, Ph.D., M.P.H., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues conducted a case-control population-based study using records from 1995 to 2022 to examine whether a subset of women with POI and their family members have an increased risk for cancer. The analyses included 613 women with POI and their relatives from two major Utah academic health care systems.
The researchers observed a significant increase in breast cancer among women with POI (odds ratio, 2.20) and a nominally significant increase in ovarian cancer. Probands with POI were aged 36.5 ± 4.3 years when diagnosed with POI and were aged 59.5 ± 12.7 years when diagnosed with cancer. Causal and candidate gene variants were identified for cancer and POI. An increased risk for breast and colon cancer (odds ratios, 1.28 and 1.50, respectively) was seen among second-degree relatives of these women. The risk for prostate cancer was increased in first-, second-, and third-degree relatives (odds ratios, 1.64, 1.54, and 1.33, respectively).
"Our data suggest that a subset of women with POI need counseling regarding future cancer risk," the authors write. "Recommendations will likely depend on underlying family history and genetic risk."
Several authors disclosed financial ties to Fabric Genomics.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Recommendations Updated for Fertility Preservation in Cancer
THURSDAY, April 10, 2025 -- In a special article published online March 19 in the Journal of Clinical Oncology, the American Society of Clinical Oncology presents updated...
CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis
MONDAY, March 24, 2025 -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study...
1990 to 2023 Saw 14 Percent Decrease in Actual Number of U.S. Births
MONDAY, March 10, 2025 -- From 1990 to 2023, there was a decrease in the number of births and in general and total fertility rates (GFRs and TFRs), according to the March 6...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.